News
(Reuters) -Neuralink has received the U.S. Food and Drug Administration's "breakthrough" tag for its device to restore ...
16hon MSN
The Food and Drug Administration is again trying to rehire some staffers who were recently fired amid mass layoffs at the ...
In an exclusive interview with physician and writer Dr. Jeremy Faust on Substack, Makary opened up about his first weeks on ...
A recall of seafood burgers by the Connecticut based company Caraluzzi's Markets has been issued a Class I risk ...
20hOpinion
Medpage Today on MSNInside the FDA: Low Morale and Uncertainty Plague StaffSeveral current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...
In an interview posted on a prominent industry blog, FDA commissioner Martin Makary also said there were no plans for major ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
2dOpinion
MedPage Today on MSNA Conversation With FDA Commissioner Marty MakaryAmong other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
Neuralink, Elon Musk's neurotechnology company, has achieved a significant milestone by receiving Breakthrough Device ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results